It takes a team to remove large, aggressive tumors

July 26, 2011 in Cancer

(Medical Xpress) -- No cancer surgery is easy, but the two operations David Bieszke underwent at Loyola University Hospital to remove an aggressive, 10-inch tumor were especially challenging.

The extended from his navel to his . It choked a major blood vessel and invaded smaller blood vessels to both kidneys.

It would take two surgeries, each lasting 6 hours, to remove the tumor. There was a significant risk that Mr. Bieszke could lose one or both kidneys. He might have to go on a heart-lung bypass machine during . There was even a chance he could bleed to death.

"I was really scared," said Mr. Bieszke, 47, who lives in Geneva, Ill.

Three days before the first surgery, David and Jennifer Bieszke got married. They had been together for 18 years, and David had asked Jennifer more than once to get married. As he faced the difficult and risky surgery, she finally said yes.

"I realized that if I lost him, I would always regret that we hadn't gotten married," Jennifer Bieszke said. "That piece of paper had become very important to me."

The two-part operation was a multidisciplinary effort that required exhaustive planning and close teamwork among four top surgeons, an anesthesiologist, the head nurse and the rest of the operating team.

"Everyone worked together so well," said surgical oncologist Dr. Margo Shoup, who coordinated the team. "It was like a beautiful sympathy."

The team was able to remove the entire tumor and save one of Mr. Bieszke's kidneys. Four weeks after his second surgery, Mr. Bieszke returned to work as an auto mechanic. He feels better now than he has in a long time.

Prior to surgery, Mr. Bieszke suffered pain near his stomach for more than a year. He took ibuprofen three or four times a day, lost his appetite and suffered .

He finally was diagnosed on April 3. An oncologist at a community hospital referred Mr. Bieszke to Dr. Shoup, because it would require an academic medical center such as Loyola to perform the highly specialized, multidisciplinary surgery.

The cancer, relatively rare, is known as vena cava sarcoma. Doctors believe it originated in the vena cava, the largest vein in the body. By the time Mr. Bieszke was diagnosed, the tumor had completely blocked the vena cava, forcing the body to grow alternative blood vessels.

The first surgery was performed April 29. Surgeons successfully removed the left side of the tumor, but were unable to save the left kidney.

The second surgery was performed June 13. Dr. Shoup worked closely with vascular surgeon Dr. Ross Milner, kidney transplant surgeon Dr. Amy Lu, cardiothoracic surgeon Dr. Robert Love, Dr. Jeffrey Hartwig and head nurse Jill Anderson.

Dr. Lu and Dr. Milner removed cancerous parts of blood vessels to the right kidney and then reconstructed the . There was a chance Dr. Lu would have to remove the kidney and, in effect, transplant it back in a different location. Fortunately, that wasn't necessary. Mr. Bieszke's right kidney stayed in place and is working normally.

Dr. Love was available in the event the tumor reached the heart and Mr. Bieszke would have to be put on a heart-lung bypass machine during the surgery. Perfusionists also were set up and ready to go on bypass at any time. Fortunately, this wasn't necessary, either.

Dr. Milner removed about 5 inches of the vena cava and Dr. Shoup removed the rest of the tumor. Dr. Hartwig infused blood to make up for blood loss and kept Mr. Biezke's vital signs stable throughout the surgery. Ms. Anderson was instrumental in making the surgery proceed without a hitch.

Today, Mr. Bieszke appears to be cancer free. But he will need regular CT scans because there's a chance the cancer could come back.

He and his wife are confident it won't.

"And even if it does, we will have Dr. Shoup," Mrs. Biezke said. "We couldn't ask for more than that."

Provided by Loyola University Health System search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

Cancer created 17 hours ago | popularity not rated yet | comments 0

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

Cancer created 17 hours ago | popularity not rated yet | comments 1

New colonoscope provides ground-breaking view of colon

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...

Cancer created May 18, 2013 | popularity 5 / 5 (2) | comments 0

ASCO: combo antibody therapy effective for melanoma

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0

Risk factors ID'd for poor cutaneous cell CA outcomes

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.